SCHEMBL9801300

SCHEMBL9801300

CCN1CCOCC1(C)C

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4550236 0.83 KDM4E (0.30)
SCHEMBL5369459 0.80
SCHEMBL16948094 0.79 MAPK1 (0.33)
SCHEMBL23555211 0.78 TP53 (0.32)
Hydrochloric Acid SCHEMBL6133166 0.78
SCHEMBL19942224 0.77
SCHEMBL2744458 0.77 GRM2 (0.31)
SCHEMBL23254096 0.77
SCHEMBL21028208 0.77 PIK3CD (0.31)
SCHEMBL2744441 0.77 KDM4E (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3227234-B1 SILICOALUMINOPHOSPHATE MOLECULAR SIEVES USING AN ORGANO-1-OXA-4-AZONIUMCYCLOHEXANE COMPOUND UOP LLC (US) 2021-05-26 EP claimed
US-20180258058-A1 ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS UOP LLC (US) 2018-09-13 US claimed
US-9815706-B2 Zeolites using an organo-1-oxa-4-azoniumcyclohexane compound UOP LLC (US) 2017-11-14 US claimed
EP-3227266-A2 ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS UOP LLC (US) 2017-10-11 EP claimed
US-9751772-B2 Aluminophosphate molecular sieves using an organo-1-oxa-4-azoniumcyclohexane compound UOP LLC (US) 2017-09-05 US claimed
US-20170044120-A1 ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS UOP LLC (US) 2017-02-16 US claimed
US-9522896-B2 Organo-1-oxa-4-azonium cyclohexane compounds UOP LLC (US) 2016-12-20 US claimed
US-20160159760-A1 ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS UOP LLC 2016-06-09 US claimed
US-20160159656-A1 ALUMINOPHOSPHATE MOLECULAR SIEVES USING AN ORGANO-1-OXA-4-AZONIUMCYCLOHEXANE COMPOUND UOP LLC 2016-06-09 US claimed
US-20160159655-A1 ZEOLITES USING AN ORGANO-1-OXA-4-AZONIUMCYCLOHEXANE COMPOUND UOP LLC 2016-06-09 US claimed
WO-2023183520-A1 COMPOSITIONS AND METHODS FOR TREATING CANCER A2A PHARMACEUTICALS, INC. (US) 2023-09-28 WO disclosed
US-20230257380-A1 TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE CULLGEN (SHANGHAI), INC. (CN) 2023-08-17 US disclosed
US-20230257380-A1 TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE CULLGEN (SHANGHAI), INC. (CN) 2023-08-17 US disclosed
EP-3227234-B1 SILICOALUMINOPHOSPHATE MOLECULAR SIEVES USING AN ORGANO-1-OXA-4-AZONIUMCYCLOHEXANE COMPOUND UOP LLC (US) 2021-05-26 EP disclosed
US-10654817-B2 Organo-1-oxa-4-azonium cyclohexane compounds UOP LLC (US) 2020-05-19 US disclosed
US-20160120850-A1 THIAZOLES AS MODULATORS OF RORyt JANSSEN PHARMACEUTICA NV (US) 2016-05-05 US disclosed
US-20150344423-A1 CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED NITROGEN-CONTAINING 5-MEMBERED HETEROCYCLES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR GAMMA PHENEX PHARMACEUTICALS AG (DE) 2015-12-03 US disclosed
US-20150322070-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 AUSPEX PHARMACEUTICALS, INC. 2015-11-12 US disclosed
US-20150175562-A1 CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED THIAZOLES AND RELATED DERIVATIVES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR[GAMMA] PHENEX PHARMACEUTICALS AG (DE) 2015-06-25 US disclosed
US-4992150-A Telomer with alpha-olefin;oil and fuel additive NIPPON OIL CO, LTD. (JP) 1991-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160120850-A1 THIAZOLES AS MODULATORS OF RORyt RORC, RORB, RORA GRM5 935/4885
US-20230257380-A1 TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE MUSK, ERBB2, NTRK1 GRM5 2403/4885
US-20150322070-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 JAK2, JAK3, PAK3 GRM5 1451/4885
US-10654817-B2 Organo-1-oxa-4-azonium cyclohexane compounds OXSR1, OXER1, OCIAD1 GRM5 2435/4885
US-20160159760-A1 ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS OXSR1, OXER1, OCIAD1 GRM5 2435/4885
US-20150175562-A1 CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED THIAZOLES AND RELATED DERIVATIVES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR[GAMMA] RORA, RORB, RORC GRM5 222/4885
US-20150344423-A1 CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED NITROGEN-CONTAINING 5-MEMBERED HETEROCYCLES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR GAMMA RORA, RORB, RORC GRM5 71/4885
US-20180258058-A1 ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS OXSR1, OXER1, OCIAD1 GRM5 2435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.